Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
IQVIA HOLDINGS INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 215.28 USD | +0.13% | -0.75% | +5.07% | |
| Dec. 07 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
| Dec. 05 | Iqvia Holdings Insider Sold Shares Worth $2,807,472, According to a Recent SEC Filing | MT |
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, thanks for standing by. At this time, I woul...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Calendar
2024-02-13
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
214.99USD
Average target price
230.52USD
Spread / Average Target
+7.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.07% | 39 236 M $ | |
| +70.40% | 41 191 M $ | |
| -55.28% | 30 484 M $ | |
| -27.34% | 27 837 M $ | |
| -28.45% | 22 245 M $ | |
| +40.26% | 22 079 M $ | |
| +4.49% | 16 633 M $ | |
| -13.10% | 11 376 M $ | |
| -17.58% | 10 762 M $ | |
| -6.17% | 10 401 M $ |
- Stock
- Equities
- Stock Iqvia Holdings Inc. - Nyse
- News Iqvia Holdings Inc.
- Transcript : IQVIA Holdings Inc., Q2 2023 Earnings Call, Aug 01, 2023
